Global Antipsychotic Drugs Market Professional Survey Report 2019
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
The global Antipsychotic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antipsychotic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antipsychotic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antipsychotic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antipsychotic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Actavis Generics
Alkermes
Bristol-Myers Squibb
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
First Antipsychotic Drugs
Second Antipsychotic Drugs
Third Antipsychotic Drugs
Segment by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
The global Antipsychotic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antipsychotic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antipsychotic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antipsychotic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antipsychotic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Actavis Generics
Alkermes
Bristol-Myers Squibb
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
First Antipsychotic Drugs
Second Antipsychotic Drugs
Third Antipsychotic Drugs
Segment by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
